Related Experiment Video
Updated: Aug 13, 2026

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
Published on: June 30, 2011
Cancer, type 2 diabetes, and ageing: news from flies and worms
1Zoologisches Institut, Universität Zürich, Switzerland. hafen@zool.unizh.ch
Abstract:
The tumour suppressor gene PTEN is, next to p53, the second most frequently mutated gene in human cancers. The genes TSC1 and TSC2 are mutated in the severe human syndrome called Tuberous Sclerosis. Patients with this disease have large benign tumours composed of large cells in the brain. The genetic dissection of pathways controlling the growth of cells, organs, and the entire organism in Drosophila has contributed to the understanding of the signalling pathways that are controlled by these two tumour suppressors. Together with studies on nutrient regulation of growth and ageing in the nematode Caenorhabditis elegans, evidence from these model organisms has moved the Insulin/IGF (IIS) and the Target Rapamycin (TOR) signalling pathway onto the centre stage of cellular growth control and made them attractive novel targets for cancer therapy. In this review, I will outline the contributions of model organism genetics to the understanding of these disease relevant pathways and highlight the evolutionary conservation of nutrient-dependent growth regulation.
Insights
Model organism genetics research has illuminated the roles of PTEN, TSC1/TSC2 tumor suppressors, and nutrient-sensing pathways like Insulin/IGF signaling (IIS) and Target of Rapamycin (TOR) in cellular growth and cancer. This work highlights conserved mechanisms for therapeutic targeting.
Area of Science:
- Genetics and Developmental Biology
- Cancer Biology
- Molecular Signaling
Background:
- The tumor suppressor gene PTEN is frequently mutated in human cancers.
- Mutations in TSC1 and TSC2 genes cause Tuberous Sclerosis, characterized by benign brain tumors.
- Understanding cellular growth control is crucial for cancer therapy.
Purpose of the Study:
- To review the contributions of model organism genetics to understanding tumor suppressor pathways.
- To highlight the role of Insulin/IGF (IIS) and Target of Rapamycin (TOR) signaling in growth control.
- To emphasize the evolutionary conservation of nutrient-dependent growth regulation.
Main Methods:
- Genetic dissection of cell and organism growth pathways in Drosophila.
- Studies on nutrient regulation of growth and aging in Caenorhabditis elegans.
- Review of existing literature on model organism contributions to signaling pathway research.
Main Results:
- Model organisms have been instrumental in dissecting pathways controlled by tumor suppressors like PTEN and TSC1/TSC2.
- Evidence from model organisms has established the central role of IIS and TOR signaling in cellular growth.
- Nutrient-dependent growth regulation mechanisms are evolutionarily conserved across species.
Conclusions:
- Model organism genetics provides critical insights into human diseases like cancer and Tuberous Sclerosis.
- The IIS and TOR pathways are key regulators of cellular growth and represent promising cancer therapeutic targets.
- Understanding conserved nutrient-sensing pathways can inform novel treatment strategies.
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology

